Home  »  Company News   »  Genprex Inc. (GNPX) poses a Brand-New Opportunity ...

Genprex Inc. (GNPX) poses a Brand-New Opportunity for Investors with beta value of -0.78

As on January 03, 2022, Genprex Inc. (NASDAQ: GNPX) got off with the flyer as it spiked 167.18% to $3.50. During the day, the stock rose to $3.62 and sunk to $1.51 before settling in for the price of $1.31 at the close. Taking a more long-term approach, GNPX posted a 52-week range of $1.17-$7.72.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


>> 7 Top Picks for the Post-Pandemic Economy << 

Meanwhile, its Annual Earning per share during the time was -50.20%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 24.00%. This publicly-traded company’s shares outstanding now amounts to $47.61 million, simultaneously with a float of $45.14 million. The organization now has a market capitalization sitting at $165.03 million. At the time of writing, stock’s 50-day Moving Average stood at $1.7500, while the 200-day Moving Average is $2.9200.

Genprex Inc. (GNPX) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Genprex Inc.’s current insider ownership accounts for 5.59%, in contrast to 12.10% institutional ownership. According to the most recent insider trade that took place on Apr 05, this organization’s Director bought 15,000 shares at the rate of 4.15, making the entire transaction reach 62,250 in total value, affecting insider ownership by 15,000.

Genprex Inc. (GNPX) Earnings and Revenue Records

If we go through the results of last quarter, which was made public on 6/29/2021, the company posted -$0.08 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.13) by $0.05. This company achieved a return on equity of -105.73. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.12 per share during the current fiscal year.

Genprex Inc.’s EPS increase for this current 12-month fiscal period is 24.00% and is forecasted to reach -0.46 in the upcoming year.

Genprex Inc. (NASDAQ: GNPX) Trading Performance Indicators

Let’s observe the current performance indicators for Genprex Inc. (GNPX). It’s Quick Ratio in the last reported quarter now stands at 36.80. The Stock has managed to achieve an average true range (ATR) of 0.29.

In the same vein, GNPX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.43, a figure that is expected to reach -0.10 in the next quarter, and analysts are predicting that it will be -0.46 at the market close of one year from today.

Technical Analysis of Genprex Inc. (GNPX)

During the previous 9 days, stock’s Stochastic %D was recorded 58.97% While, its Average True Range was 0.3700.

>> 7 Top Picks for the Post-Pandemic Economy << 

Raw Stochastic average of Genprex Inc. (GNPX) in the period of the previous 100 days is set at 95.10%, which indicates a major rise in contrast to 95.10% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 407.60% that was higher than 180.98% volatility it exhibited in the past 100-days period.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

Sign up for Our Newsletter Now! Discover which stocks to trade!
100% Free. Stop Anytime. No Spam